BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19027853)

  • 1. The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities.
    Kloss A; Henklein P; Siele D; Schmolke M; Apcher S; Kuehn L; Sheppard PW; Dahlmann B
    Eur J Pharm Biopharm; 2009 May; 72(1):219-25. PubMed ID: 19027853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of flavonoids on 26S proteasome activity.
    Chang TL
    J Agric Food Chem; 2009 Oct; 57(20):9706-15. PubMed ID: 19795881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ajoene, a natural antitumor small molecule, on human 20S proteasome activity in vitro and in human leukemic HL60 cells.
    Xu B; Monsarrat B; Gairin JE; Girbal-Neuhauser E
    Fundam Clin Pharmacol; 2004 Apr; 18(2):171-80. PubMed ID: 15066131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian 26S proteasomes remain intact during protein degradation.
    Kriegenburg F; Seeger M; Saeki Y; Tanaka K; Lauridsen AM; Hartmann-Petersen R; Hendil KB
    Cell; 2008 Oct; 135(2):355-65. PubMed ID: 18957208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity labeling of the proteasome by a belactosin A derived inhibitor.
    Hasegawa M; Kinoshita K; Nishimura C; Matsumura U; Shionyu M; Ikeda S; Mizukami T
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5668-71. PubMed ID: 18801655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
    Imbach P; Lang M; García-Echeverría C; Guagnano V; Noorani M; Roesel J; Bitsch F; Rihs G; Furet P
    Bioorg Med Chem Lett; 2007 Jan; 17(2):358-62. PubMed ID: 17095212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of lipopeptides for inhibiting 20S proteasomes.
    Basse N; Papapostolou D; Pagano M; Reboud-Ravaux M; Bernard E; Felten AS; Vanderesse R
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3277-81. PubMed ID: 16630721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assays of proteasome-dependent cleavage products.
    Tenzer S; Schild H
    Methods Mol Biol; 2005; 301():97-115. PubMed ID: 15917629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic mechanisms underlying mitochondrial degradation in the ocular lens.
    Zandy AJ; Bassnett S
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):293-302. PubMed ID: 17197546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aaptamine, an alkaloid from the sponge Aaptos suberitoides, functions as a proteasome inhibitor.
    Tsukamoto S; Yamanokuchi R; Yoshitomi M; Sato K; Ikeda T; Rotinsulu H; Mangindaan RE; de Voogd NJ; van Soest RW; Yokosawa H
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3341-3. PubMed ID: 20451377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasomes.
    Dahlmann B
    Essays Biochem; 2005; 41():31-48. PubMed ID: 16250896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High affinity Zn2+ inhibitory site(s) for the trypsin-like peptidase of the 20S proteasome.
    Chouduri AU; Mishina K; Shimizu T; Yamazaki M; Tokumoto T; Yamada S
    Arch Biochem Biophys; 2008 Sep; 477(1):113-20. PubMed ID: 18486588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors.
    Nakamura H; Watanabe M; Ban HS; Nabeyama W; Asai A
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3220-4. PubMed ID: 19428245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphosphorylation of rat liver proteasome subunits: the effects of ethanol and okadaic acid are compared.
    Bardag-Gorce F; Venkatesh R; Li J; French BA; French SW
    Life Sci; 2004 Jun; 75(5):585-97. PubMed ID: 15158368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.
    Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L
    J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the 20S proteosome by a protein proteinase inhibitor: evidence that a natural serine proteinase inhibitor can inhibit a threonine proteinase.
    Yabe K; Koide T
    J Biochem; 2009 Feb; 145(2):217-27. PubMed ID: 19054805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28.
    Brychcy M; Kuckelkorn U; Hausdorf G; Egerer K; Kloetzel PM; Burmester GR; Feist E
    Arthritis Rheum; 2006 Jul; 54(7):2175-83. PubMed ID: 16802355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5,6,3',4'-Tetrahydroxy-7-methoxyflavone as a novel potential proteasome inhibitor.
    Chang TL; Ding HY; Teng KN; Fang YC
    Planta Med; 2010 Jul; 76(10):987-94. PubMed ID: 20195959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell-permeable inhibitor and activity-based probe for the caspase-like activity of the proteasome.
    van Swieten PF; Samuel E; Hernández RO; van den Nieuwendijk AM; Leeuwenburgh MA; van der Marel GA; Kessler BM; Overkleeft HS; Kisselev AF
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3402-5. PubMed ID: 17442566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cytoplasmic proteasome proteinase activities are altered in chronic renal failure.
    Peerce BE; Clarke RD
    Arch Biochem Biophys; 2005 Dec; 444(2):84-91. PubMed ID: 16293221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.